These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1144 related items for PubMed ID: 22353431

  • 1. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M, Liu M, Xiong M, Gong J, Tan X.
    J Ethnopharmacol; 2012 May 07; 141(1):111-8. PubMed ID: 22353431
    [Abstract] [Full Text] [Related]

  • 2. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S, Li Y, Huang YJ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep 07; 27(9):1003-6. PubMed ID: 21906476
    [Abstract] [Full Text] [Related]

  • 3. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L, Radovits T, Szabó G, Mózes MM, Rosivall L, Kökény G.
    Nephrol Dial Transplant; 2013 Jul 07; 28(7):1751-61. PubMed ID: 23203993
    [Abstract] [Full Text] [Related]

  • 4. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S, Li Y, Zhao J, Zhang J, Huang Y.
    Biol Blood Marrow Transplant; 2013 Apr 07; 19(4):538-46. PubMed ID: 23295166
    [Abstract] [Full Text] [Related]

  • 5. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
    Hartner A, Cordasic N, Menendez-Castro C, Volkert G, Yabu JM, Kupraszewicz-Hutzler M, Rascher W, Hilgers KF.
    Am J Physiol Renal Physiol; 2010 Nov 07; 299(5):F1151-7. PubMed ID: 20826576
    [Abstract] [Full Text] [Related]

  • 6. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
    Zhang J, Fu H, Xu Y, Niu Y, An X.
    J Nat Med; 2016 Oct 07; 70(4):740-8. PubMed ID: 27255369
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
    Lee EY, Kim GT, Hyun M, Kim S, Seok S, Choi R, Lee MY, Chung CH.
    Nephrol Dial Transplant; 2012 Nov 07; 27(11):4069-79. PubMed ID: 22892126
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A, Wiggins KJ, Cox AJ, Zhang Y, Gilbert RE, Kelly DJ.
    Nephrology (Carlton); 2011 Aug 07; 16(6):573-81. PubMed ID: 21342330
    [Abstract] [Full Text] [Related]

  • 9. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H, Gao T, Raup-Konsavage WM, Cooper TK, Bronson SK, Reeves WB, Awad AS.
    Kidney Int; 2017 Mar 07; 91(3):671-682. PubMed ID: 27914709
    [Abstract] [Full Text] [Related]

  • 10. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH, Jandeleit-Dahm KA.
    Diabetologia; 2016 Feb 07; 59(2):379-89. PubMed ID: 26508318
    [Abstract] [Full Text] [Related]

  • 11. β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.
    Zhang W, Miao J, Ma C, Han D, Zhang Y.
    Peptides; 2012 Aug 07; 36(2):186-91. PubMed ID: 22687367
    [Abstract] [Full Text] [Related]

  • 12. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J, Chen Y, Luo Y, Gui D, Huang J, He D.
    Eur J Pharmacol; 2014 Aug 05; 736():86-94. PubMed ID: 24809932
    [Abstract] [Full Text] [Related]

  • 13. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats.
    Sohn E, Kim J, Kim CS, Kim YS, Jang DS, Kim JS.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):733-8. PubMed ID: 19944074
    [Abstract] [Full Text] [Related]

  • 14. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K, Raff AC, Schiffer M, Böttinger EP.
    Diabetes; 2006 Jan 01; 55(1):225-33. PubMed ID: 16380497
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.
    Xiao T, Guan X, Nie L, Wang S, Sun L, He T, Huang Y, Zhang J, Yang K, Wang J, Zhao J.
    Mol Cell Biochem; 2014 Sep 01; 394(1-2):145-54. PubMed ID: 24850187
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
    Toyonaga J, Tsuruya K, Ikeda H, Noguchi H, Yotsueda H, Fujisaki K, Hirakawa M, Taniguchi M, Masutani K, Iida M.
    Nephrol Dial Transplant; 2011 Aug 01; 26(8):2475-84. PubMed ID: 21220752
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM, Wang H, Ren XJ, Liu JP, Wang JY.
    Nephrology (Carlton); 2012 May 01; 17(4):380-9. PubMed ID: 22243699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.